Lung cancer has some of the highest morbidity and mortality rates of all cancers, and an
important risk factor for mortality in patients with lung cancer is tumor metastasis. Even if a …

Rationale: Current guidelines for non–small cell lung cancer (NSCLC) mediastinal staging
recommend starting invasive staging with endobronchial ultrasound-guided transbronchial …

Preoperative mediastinal staging is crucial in the management of patients with non-small
cell lung cancer (NSCLC), especially to define prognosis and the most proper treatment. To …

The landscape of care for early-stage non–small cell lung cancer continues to evolve. While
some of the developments do not seem as dramatic as what has occurred in advanced …

Mediastinal staging is a crucial step in the management of patients with NSCLC. With the
recent development of novel techniques, mediastinal staging has evolved from an activity of …

Mediastinal lymph node staging in the setting of known or suspected lung cancer is
supported by multiple professional societies as standard for high-quality care, yet proper …

The evaluation of mediastinal lymph nodes is critical for the correct staging of patients with
lung cancer (LC). Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS …

Objectives The aim of this study is to analyze the accuracy of video-assisted
mediastinoscopic lymphadenectomy (VAMLA) and the unsuspected (u) N2/3 rates in …

The staging of mediastinal lymph nodes is essential for planning the most adequate
treatment for patients with non-small cell lung cancer (NSCLC). For this reason, the current …

In 2015, around 4400 individuals received a diagnosis of lung cancer, and Switzerland
recorded approximately 3200 deaths related to lung cancer. Advances in detection, such as …